Knockdown of NRP-1 or pretreatment of Epstein–Barr virus (EBV) with soluble NRP-1 suppresses EBV infection of human nasopharyngeal epithelial cells, while up-regulation of NRP-1 by overexpression enhances EBV infection [7]. The gene discussed is NRP1; the disease is Epstein-Barr virus infection.